MT-2 (Melanotan 2 Acetate) 10mg

Description

Product Overview

Melanotan-2 (MT-2) is a synthetic cyclic heptapeptide supplied by PeptaCo for qualified laboratory research. It is a potent melanocortin receptor agonist with higher affinity than Melanotan-1. Melanotan-2 is widely referenced in melanocortin receptor research and neuroscience investigations.

Key Product Details

• Product Name: Melanotan-2 (MT-2)
• Specification: 10mg per vial
• Product Form: Lyophilized powder
• Category: Neuro Research Peptides — Melanocortin Agonist
• Peptide Structure: Cyclic heptapeptide (Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2)

Chemical Identity

Melanotan-2 is a cyclic analog of α-MSH with a lactam bridge between Asp and Phe residues. Molecular Formula: C₅₀H₆₈N₁₄O₉. Molecular Weight: ~1025 Da. The cyclic structure provides enhanced receptor binding affinity and metabolic stability compared to linear analogs.

Research Context

Melanotan-2 is extensively studied in melanocortin research for its high affinity at multiple melanocortin receptors (MC1-R, MC3-R, MC4-R). It is commonly referenced in investigations of receptor pharmacology, structure-activity relationships, and peptide-mediated behavioral responses. PeptaCo supplies Melanotan-2 in high-purity format for qualified laboratory customers.

Storage and Handling

Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.

Documentation and Quality

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.

Important Notice

This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.